US Patent Issued to BAHCESEHIR UNIVERSITESI on June 3 for "Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor" (Turkish Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,368, issued on June 3, was assigned to BAHCESEHIR UNIVERSITESI (Istanbul).

"Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor" was invented by Berna Dogan (Besiktas/Istanbul, Turkey), Serdar Durdagi (Besiktas/Istanbul, Turkey), Gurbet Cacan (Besiktas/Istanbul, Turkey), Seyma Calis (Besiktas/Istanbul, Turkey), Timucin Avsar (Besiktas/Istanbul, Turkey) and Muge Didem Orhan (Besiktasa/Istanbul, Turkey).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2."

The patent was fil...